Basepaws is a petcare genetics company that builds early detection health risk tests based on genetic and microbiome data. Basepaws is committed to companion animal health research, and it has the world’s first at-home genetic testing platform for cats. Founded in 2017 by Anna Skaya, the company is based in Los Angeles, CA.
On June 22, 2022, Zoetis Inc. (NYSE:ZTS) announced the completion of its acquisition of Basepaws. The acquisition was first announced on June 7th, and the financial terms of the transaction were not disclosed.
“The addition of Basepaws will enhance our portfolio in the precision animal health space and inform our future pipeline of petcare innovations. Working together, we can continue to provide veterinarians and pet owners with more comprehensive ways to proactively manage the health, wellness and quality of care for their animals.” - said Zoetis CEO Kristin Peck.
Company Details
- Employees
- 31
- Founded
- -
- Address
- 1820 W Carson Blvd,
- Phone
- (415) 634-PETS
- me****@****aws.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- basepaws.com
- Keywords
- pettech, startup, biotech, feline health, animal health, microbiome, genetics, animal genetics, felines, cat behavior, dental health.
- HQ
- Torrance, California
Basepaws Questions
Basepaws's helpline number is (415) 634-PETS
Basepaws's website is basepaws.com
Basepaws's LinkedIn profile is https://www.linkedin.com/company/basepaws
Basepaws has
31 employees.
View email and phone details for 31
employees at Basepaws.
Basepaws's industry is
Biotechnology Research
Basepaws's top competitors are
Petco Love,
Petdx,
Embark Veterinary,
Animalbiome,
Petdesk,
Zoetis,
Modern Animal,
Loyal,
Fidocure®,
Wisdom Panel.
Basepaws's support email address is meow@basepaws.com
Basepaws's categories are Biotechnology Research
Basepaws's founding year is 2017
